SCOPUS 정보 검색 플랫폼

AIDS

Volumn 20, Issue 8, 2006, Pages 1212-1213

Haemolytic anaemia associated with efavirenz [6]

(4) Freercks, Robert J a Mehta, Ushma a Stead, David F b Meintjes, Graeme A a,b,c

a UNIVERSITY OF CAPE TOWN (South Africa)

b GF Jooste Hospital (South Africa)

c GF Jooste Hospital (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; PREDNISONE; STAVUDINE;

ADULT; CASE REPORT; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HEMOLYTIC ANEMIA; HUMAN; LETTER; PRIORITY JOURNAL;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; OXAZINES; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 33646881059 PISSN: 02699370 EISSN: None Source Type: Journal
DOI: 10.1097/01.aids.0000226970.04504.a8 Document Type: Letter

Times cited : (8)

References (6)

1
- 11144357656
- Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: A randomised open-label trial, the 2NN Study
- van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Cazzard B, et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet 2004; 363:1253-1263.
- (2004) Lancet , vol.363 , pp. 1253-1263
- Van Leth, F.¹ Phanuphak, P.² Ruxrungtham, K.³ Baraldi, E.⁴ Miller, S.⁵ Cazzard, B.⁶

2
- 20144370563
- Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs
- Ananworanich J, Moor Z, Siangphoe U, Chan J, Cardiello P, Duncombe C, et al. Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs. AIDS 2005; 19:185-192.
- (2005) AIDS , vol.19 , pp. 185-192
- Ananworanich, J.¹ Moor, Z.² Siangphoe, U.³ Chan, J.⁴ Cardiello, P.⁵ Duncombe, C.⁶

3
- 12744270628
- South African National Department of Health. South Africa: Jacana
- National Antiretroviral Treatment Guidelines, South African National Department of Health. South Africa: Jacana; 2004.
- (2004) National Antiretroviral Treatment Guidelines

4
- 0344760902
- October 6
- Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. October 6, 2005.
- (2005) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

5
- 33646874400
- MSD (Pty) Ltd
- Product Information: Stocrin®, MSD (Pty) Ltd; 1999.
- (1999) Product Information: Stocrin®

6
- 33646896538
- Evaluation of cutaneous cross-toxicity between efavirenz and nevirapine-containing regimens in clinical practice
- Paris, July
- Torralba M, Neira M, Rubio R, López-Pedraza M, Tamargo L, Moreno V, et al. Evaluation of cutaneous cross-toxicity between efavirenz and nevirapine-containing regimens in clinical practice. Fifth International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Paris, July 2003.
- (2003) Fifth International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
- Torralba, M.¹ Neira, M.² Rubio, R.³ López-Pedraza, M.⁴ Tamargo, L.⁵ Moreno, V.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.